An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

MLA

Qing Kay Li, et al. “An Integrated Proteomic and Glycoproteomic Approach Uncovers Differences in Glycosylation Occupancy from Benign and Malignant Epithelial Ovarian Tumors.” Clinical Proteomics, vol. 14, no. 1, May 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12014-017-9152-2.

APA

Qing Kay Li, Punit Shah, Yuan Tian, Yingwei Hu, Richard B. S. Roden, Hui Zhang, & Daniel W. Chan. (2017). An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors. Clinical Proteomics, 14(1), 1–9. https://doi.org/10.1186/s12014-017-9152-2

Chicago

Qing Kay Li, Punit Shah, Yuan Tian, Yingwei Hu, Richard B. S. Roden, Hui Zhang, and Daniel W. Chan. 2017. “An Integrated Proteomic and Glycoproteomic Approach Uncovers Differences in Glycosylation Occupancy from Benign and Malignant Epithelial Ovarian Tumors.” Clinical Proteomics 14 (1): 1–9. doi:10.1186/s12014-017-9152-2.